Biography
Dr. Roden is researching nonneoplastic lung diseases including interstitial lung diseases and lung allografts. She developed and maintains a large database of lung allograft biopsies. Studies in interstitial lung disease, closely align with Dr. Roden's interest in biomarkers for personalized medicine in thoracic tumors, as those are commonly immune-mediated. While immune-mediated therapy appears to be a very effective tumor treatment, side effects (including effects on the lungs) are not well studied. Dr. Roden's studies are investigating histologic changes in the lungs of patients treated with immune checkpoint inhibitors with the goal of early recognition and prevention.
She is also researching lung tumors, specifically neuroendocrine and salivary gland-type tumors, malignant mesotheliomas, and mediastinal neoplasms such as thymic epithelial tumors and primary mediastinal germ cell tumors from morphologic, immunophenotypical, molecular and clinical aspects. She developed and maintains a database that now includes over 600 patients with these rare tumors. This database forms the foundation of many of her studies.
She is also researching lung tumors, specifically neuroendocrine and salivary gland-type tumors, malignant mesotheliomas, and mediastinal neoplasms such as thymic epithelial tumors and primary mediastinal germ cell tumors from morphologic, immunophenotypical, molecular and clinical aspects. She developed and maintains a database that now includes over 600 patients with these rare tumors. This database forms the foundation of many of her studies.